HCA Healthcare (NYSE:HCA) PT Raised to $396.00 at SVB Leerink

HCA Healthcare (NYSE:HCA) had its target price increased by SVB Leerink from $367.00 to $396.00 in a report published on Wednesday, Benzinga reports. SVB Leerink currently has an outperform rating on the stock.

Other analysts also recently issued research reports about the stock. Wells Fargo & Company lifted their target price on shares of HCA Healthcare from $303.00 to $315.00 and gave the company an equal weight rating in a report on Thursday, March 28th. Robert W. Baird initiated coverage on shares of HCA Healthcare in a report on Thursday, May 30th. They issued an outperform rating and a $396.00 target price for the company. Barclays lifted their target price on shares of HCA Healthcare from $367.00 to $376.00 and gave the company an overweight rating in a report on Wednesday, July 10th. Truist Financial lifted their target price on shares of HCA Healthcare from $375.00 to $390.00 and gave the company a buy rating in a report on Wednesday. Finally, Royal Bank of Canada boosted their price target on shares of HCA Healthcare from $322.00 to $329.00 and gave the stock an outperform rating in a research note on Monday, April 29th. Four research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of Moderate Buy and an average target price of $339.72.

HCA Healthcare Trading Up 0.6 %

Shares of HCA Healthcare stock opened at $354.78 on Wednesday. The firm has a market capitalization of $92.92 billion, a PE ratio of 17.69, a P/E/G ratio of 1.35 and a beta of 1.68. HCA Healthcare has a twelve month low of $215.96 and a twelve month high of $356.30. The firm’s 50-day moving average price is $330.12 and its 200 day moving average price is $323.11. The company has a current ratio of 1.06, a quick ratio of 1.02 and a debt-to-equity ratio of 27.11.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The firm had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. During the same period last year, the company posted $4.29 EPS. HCA Healthcare’s quarterly revenue was up 10.3% compared to the same quarter last year. On average, sell-side analysts predict that HCA Healthcare will post 22.44 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be given a $0.66 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a yield of 0.74%. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.16%.

Insider Activity at HCA Healthcare

In other news, SVP Jeffrey E. Cohen sold 1,650 shares of the company’s stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $313.00, for a total value of $516,450.00. Following the completion of the sale, the senior vice president now directly owns 5,185 shares of the company’s stock, valued at $1,622,905. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, SVP Kathryn A. Torres sold 973 shares of the business’s stock in a transaction dated Thursday, May 2nd. The shares were sold at an average price of $312.00, for a total transaction of $303,576.00. Following the transaction, the senior vice president now directly owns 22,365 shares in the company, valued at $6,977,880. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Jeffrey E. Cohen sold 1,650 shares of the company’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $313.00, for a total transaction of $516,450.00. Following the transaction, the senior vice president now owns 5,185 shares in the company, valued at $1,622,905. The disclosure for this sale can be found here. Insiders sold a total of 12,397 shares of company stock valued at $3,921,929 over the last ninety days. Insiders own 1.60% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in HCA. Pacer Advisors Inc. grew its position in HCA Healthcare by 8.4% during the fourth quarter. Pacer Advisors Inc. now owns 15,488 shares of the company’s stock worth $4,192,000 after buying an additional 1,205 shares during the period. Assenagon Asset Management S.A. lifted its holdings in shares of HCA Healthcare by 2.9% in the fourth quarter. Assenagon Asset Management S.A. now owns 90,551 shares of the company’s stock valued at $24,510,000 after purchasing an additional 2,522 shares in the last quarter. Ritholtz Wealth Management lifted its holdings in shares of HCA Healthcare by 24.9% in the fourth quarter. Ritholtz Wealth Management now owns 8,012 shares of the company’s stock valued at $2,169,000 after purchasing an additional 1,596 shares in the last quarter. Inscription Capital LLC lifted its stake in shares of HCA Healthcare by 12.9% during the fourth quarter. Inscription Capital LLC now owns 3,445 shares of the company’s stock valued at $932,000 after buying an additional 394 shares during the period. Finally, Global Retirement Partners LLC lifted its stake in shares of HCA Healthcare by 62.3% during the fourth quarter. Global Retirement Partners LLC now owns 10,810 shares of the company’s stock valued at $3,036,000 after buying an additional 4,150 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.